AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21255610
Drug: NIM811 monotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NIM811 monotherapy (doses of 10 to 600 mg orally once or twice daily)
Trial: 21255610
Drug: NIM811 (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NIM811 (600 mg bid) in combination with pegylated interferon alpha (PEG‐IFN‐α)
Trial: 10961521
Drug: CHO-electrolyte solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHO-electrolyte solution (CE)
Trial: 2868736
Drug: Thiopental loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental loading added to standard therapy
Trial: 27224908
Drug: Tapentadol ER
RxNorm normalized name: tapentadol Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tapentadol ER (25-250 mg)
Trial: 20197167
Drug: Over-the-counter analgesics
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Over-the-counter analgesics (OTC)
Trial: 18550582
Drug: Daily free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily free distribution program
Trial: 9682041
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg of alendronate per day
Trial: 9682041
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of alendronate per day
Trial: 17190893
Drug: Alendronate (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate (both doses)
Trial: 7897120
Drug: No thrombolytic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No thrombolytic therapy (baseline ECG)
Trial: 2482549
Drug: Placebo (subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (subcutaneous injections)
Trial: 21988334
Drug: Tolvaptan 30
RxNorm normalized name: tolvaptan 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolvaptan 30 mg with ketoconazole 200 mg once daily for 3 days
Trial: 21988334
Drug: Tolvaptan 240
RxNorm normalized name: Tolvaptan
DrugBank: Tolvaptan (DB06212)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tolvaptan 240 mg with rifampicin 600 mg once daily for 7 days
Trial: 29484495
Drug: Rotigotine transdermal
RxNorm normalized name: Rotigotine Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rotigotine transdermal patch
Trial: 17935234
Drug: Rotigotine transdermal
RxNorm normalized name: Rotigotine Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rotigotine transdermal patch (doses ≤8 mg/24 h)
Trial: 12483368
Drug: Amifostine (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amifostine (500 mg on each day of chemotherapy)
Trial: 9616310
Drug: Antituberculous chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antituberculous chemotherapy
Trial: 9616310
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no antituberculous chemotherapy)
Trial: 2613389
Drug: Solid paracetamol
RxNorm normalized name: Corydalis solida whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solid paracetamol dosage form (tablets) with meal enriched in dietary fiber
Trial: 2613389
Drug: Liquid and
RxNorm normalized name: KIT, LIQUID AND TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liquid and solid paracetamol dosage forms
Trial: 870376
Drug: oral mannitol
RxNorm normalized name: Mannitol
DrugBank: Mannitol (DB00742)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: oral mannitol to induce diarrhea
Trial: 30694697
Drug: Dasotraline 4
RxNorm normalized name: Dasotraline
DrugBank: Dasotraline (DB12305)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dasotraline 4 mg/day
Trial: 21324520
Drug: Daily beclomethasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily beclomethasone (twice daily, 40 μg per puff)
Trial: 21324520
Drug: Combined (twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined (twice daily beclomethasone with beclomethasone plus albuterol as rescue)
Trial: 21324520
Drug: Rescue beclomethasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rescue beclomethasone (twice daily placebo with beclomethasone plus albuterol as rescue)
Trial: 17580440
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment (Quchi, Lieque, Yuji, Neiguan, Zusanli, Sanyinjiao, Taixi) once daily for 12 days
Trial: 17580440
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group treated with anti-asthma drugs (Cromolyn sodium, Albuterol, fenoterol)
Trial: 17580440
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment for moderate and severe asthma
Trial: 17580440
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group treated with anti-asthma drugs
Trial: 12575376
Drug: Xuejie Jiawei
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xuejie Jiawei Decoction No. II, one dose per day for 5 days, starting from the 11th day after abortion
Trial: 9622044
Drug: Clonidine plus
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine plus neuroleptic (dosage of clonidine varied from 0.2 to 0.6 mg per day, neuroleptic averaged 34 mg per day of haloperidol equivalents)
Trial: 9622044
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus neuroleptic (neuroleptic averaged 34 mg per day of haloperidol equivalents)
Trial: 1769029
Drug: Continuous patch
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous patch application (Group A)
Trial: 1769029
Drug: First dose
RxNorm normalized name: Cow first milk
DrugBank: Bos taurus colostrum (DB19249)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First dose of the nitroglycerin patch
Trial: 28093604
Drug: 5% 5-fluorouracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% 5-fluorouracil (5-FU) pretreatment for 7 days, twice daily before daylight-mediated photodynamic therapy (PDT)
Trial: 28093604
Drug: Daylight-mediated photodynamic
RxNorm normalized name: carbinoxamine maleate Oral Solution [Pediatex]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daylight-mediated photodynamic therapy (PDT) alone
Trial: 22392326
Drug: Rolls fortified
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rolls fortified with microencapsulated iron sulfate (4 mg iron each), offered once a day, five days a week for 24 weeks.
Trial: 20662314
Drug: Rosiglitazone maleate
RxNorm normalized name: Rosiglitazone Maleate
DrugBank: Rosiglitazone (DB00412)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rosiglitazone maleate sustained-release floating microspheres
Trial: 20662314
Drug: Commercial tablets
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Commercial tablets (control)
Trial: 18363603
Drug: Erythropoiesis stimulating
RxNorm normalized name: Erythropoiesis stimulating agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythropoiesis stimulating agents (ESA)
Trial: 1549650
Drug: l-fenfluramine (l-FF)
RxNorm normalized name: fenfluramine
DrugBank: Fenfluramine (DB00574)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-fenfluramine (l-FF) + d-amphetamine (d-amp)
Trial: 1549650
Drug: l-fenfluramine (l-FF)
RxNorm normalized name: fenfluramine
DrugBank: Fenfluramine (DB00574)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-fenfluramine (l-FF)
Trial: 27575854
Drug: KLOX BioPhotonic
RxNorm normalized name: Kloxxado
DrugBank: Naloxone (DB01183)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: KLOX BioPhotonic System (LED blue light device with photo-converter chromophores), treated for 6 weeks (twice weekly)
Trial: 22459647
Drug: No additional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No additional treatment (group A)
Trial: 6089304
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg twice daily for 4 weeks
Trial: 6119777
Drug: Ranitidine after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine after initial treatment
Trial: 6119777
Drug: Ranitidine after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine after initial placebo treatment
Trial: 31358470
Drug: 4-week walking
RxNorm normalized name: milnacipran
DrugBank: Milnacipran (DB04896)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 4-week walking intervention aimed at increasing daily steps
Trial: 23516092
Drug: Gushen Pian
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gushen Pian (double-blind treatment group)
Trial: 11528230
Drug: Blood flow
RxNorm normalized name: NITRIC OXIDE 400 mg in 500 mg TOPICAL CAPSULE [Bio NO Brain Care (Helps improve Brain blood flow and body temperature, Fermented Garlic powder)]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood flow rate (Qb) 300 ml/min
Trial: 11528230
Drug: Blood flow
RxNorm normalized name: NITRIC OXIDE 400 mg in 500 mg TOPICAL CAPSULE [Bio NO Brain Care (Helps improve Brain blood flow and body temperature, Fermented Garlic powder)]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood flow rate (Qb) 200 ml/min
Trial: 11528230
Drug: Blood flow
RxNorm normalized name: NITRIC OXIDE 400 mg in 500 mg TOPICAL CAPSULE [Bio NO Brain Care (Helps improve Brain blood flow and body temperature, Fermented Garlic powder)]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood flow rate (Qb) 400 ml/min
Trial: 9935259
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg trovafloxacin by mouth
Trial: 9935259
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g cefoxitin by i.v. infusion
Trial: 29565660
Drug: Standard care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard care plus Oral Health 4 Life (OH4L)
Trial: 28991280
Drug: Platelet-rich plasma
RxNorm normalized name: PLATELET-RICH PLASMA, AUTOLOGOUS
DrugBank: Platelet Rich Plasma (DB19295)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platelet-rich plasma (PRP) administration during internal fracture reduction
Trial: 12852707
Drug: Fluvastatin ER
RxNorm normalized name: fluvastatin Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin ER 80 mg QD
Trial: 12852707
Drug: Fluvastatin IR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin IR 40 mg QD
Trial: 10665628
Drug: Citalopram 10
RxNorm normalized name: citalopram 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram 10 mg/day
Trial: 25500685
Drug: Citalopram 40
RxNorm normalized name: citalopram 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram 40 mg/day
Trial: 8604406
Drug: Treatment of
RxNorm normalized name: DRUGS FOR TREATMENT OF LEPRA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment of catheter-related infection
Trial: 8604406
Drug: 4 to
RxNorm normalized name: LMX 4 Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 to 6 weeks of therapy for infection in men
Trial: 15500134
Drug: RAS blockers
RxNorm normalized name: RAS
DrugBank: Rasagiline (DB01367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: RAS blockers
Trial: 28095795
Drug: Intrathecal magnesium
RxNorm normalized name: beractant
DrugBank: Beractant (DB06761)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrathecal magnesium sulfate (50 mg)
Trial: 8384733
Drug: Subcutaneous vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous vaccine
Trial: 19728561
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation of fexofenadine
Trial: 19728561
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation of fexofenadine
Trial: 11563193
Drug: Dan Shao
RxNorm normalized name: Dan shen suan b
DrugBank: Salvianolic acid B (DB19313)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dan Shao Tang and western medicine
Trial: 9876347
Drug: hGH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hGH treatment
Trial: 8039024
Drug: Topical lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical lidocaine (anaesthesia of the nose)
Trial: 2930092
Drug: Caffeine (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (250 mg of caffeine sodium benzoate)
Trial: 17471830
Drug: Pulsed electromagnetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed electromagnetic fields (PEMF) therapy
Trial: 11797269
Drug: Chemotherapy (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (standard treatment)
Trial: 11797269
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of epirubicin-cisplatin-continuous 5FU (ECF)
Trial: 11797269
Drug: Radio-chemotherapy
RxNorm normalized name: Valerianae radix
DrugBank: Valerian (DB13196)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radio-chemotherapy
Trial: 11797269
Drug: 5FU alone,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5FU alone, 5FU-cisplatin, or 5FU-mitomycin (as preoperative or exclusive treatment)
Trial: 7817618
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg bisoprolol once daily
Trial: 21035560
Drug: Salmeterol 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol 200 μg
Trial: 30836363
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg lycopene, 5.8 mg phytoene and phytofluene, 0.8 mg β-carotene, 5.6 mg tocopherols from tomato extract, and 4 mg carnosic acid from rosemary extract per day
Trial: 30993855
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine 100 units/mL (Gla-100)
Trial: 9432453
Drug: Immediate treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate treatment group
Trial: 9848758
Drug: Endotracheal continuous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endotracheal continuous positive airway pressure (ETCPAP) after rescue surfactant therapy
Trial: 7815711
Drug: Pipecuronium bromide
RxNorm normalized name: pipecuronium bromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pipecuronium bromide 0.04 mg.kg‐1
Trial: 7815711
Drug: Vecuronium bromide
RxNorm normalized name: Vecuronium Bromide
DrugBank: Vecuronium (DB01339)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vecuronium bromide 0.08 mg.kg‐1
Trial: 2805024
Drug: Cisapride, 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride, 0.1 to 0.2 mg/kg three times daily for up to four weeks
Trial: 21595543
Drug: Traditional Japanese
RxNorm normalized name: Japanese encephalitis virus
DrugBank: Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) (DB10769)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Japanese massage therapy (40‐minute full-body massage)
Trial: 20705788
Drug: Dexmedetomidine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine infusion (IV dexmedetomidine 2 μg · kg(‐1) over 10 minutes, followed by 0.7 μg · kg(‐1) · h(‐1))
Trial: 20705788
Drug: Fentanyl bolus
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl bolus (IV fentanyl 1 μg · kg(‐1))
Trial: 15847998
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg piroxicam freeze-dried tablet (Proxalyoc, Cephalon)
Trial: 15847998
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg piroxicam capsule (Feldene, Pfizer)
Trial: 10914864
Drug: Calcitriol (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcitriol (0.5 microg) and 1200 mg calcium daily
Trial: 8985030
Drug: Short course
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short course radiotherapy (20 Gy in 1 week, daily dose 4 Gy)
Trial: 8985030
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (30 Gy in 3 weeks, daily dose 2 Gy)
Trial: 1569224
Drug: 0.2% chlorhexidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2% chlorhexidine digluconate (CHX) used in oral irrigator, 2 x daily for 56 days
Trial: 1569224
Drug: Placebo used
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo used in oral irrigator
Trial: 236108
Drug: Flurazepam, 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurazepam, 30 mg
Trial: 21543662
Drug: Atomoxetine (10,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine (10, 40, 90, or 120 mg single dose; 40 or 60 mg twice a day for 7 days)
Trial: 21125038
Drug: Revascularisation plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Revascularisation plus medical therapy
Trial: 15696181
Drug: Pilocarpine hydrochloride
RxNorm normalized name: Pilocarpine Hydrochloride
DrugBank: Pilocarpine (DB01085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pilocarpine hydrochloride 5 mg tablet
Trial: 17115983
Drug: Topiramate 200
RxNorm normalized name: topiramate 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate 200 mg/day
Trial: 9201655
Drug: Intravenous gammaglobulin
RxNorm normalized name: Human gammaglobulin
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous gammaglobulin (1 gm/kg, max 1 litre of 6 gm/100 ml in 10% w/v maltose solution)
Trial: 9201655
Drug: Dummy solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dummy solution (10% w/v maltose solution with 1% albumin of equivalent volume)
Trial: 1332529
Drug: S(+)‐ketamine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S(+)‐ketamine (1 mg/kg BW)
Trial: 15886286
Drug: Nitroglycerin (NIT)
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin (NIT) at a starting dose of 10 microg/min
Trial: 15886286
Drug: Nitroprusside (NIP)
DrugBank: Nitroprusside (DB00325)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Nitroprusside (NIP) at a starting dose of 0.25 microg/kg/min
Trial: 11840436
Drug: COBRA therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COBRA therapy (combination of prednisolone, methotrexate, and sulfasalazine)
Trial: 15146408
Drug: SSZ monotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SSZ monotherapy
Trial: 15338488
Drug: COBRA therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COBRA therapy
Trial: 29083444
Drug: Development of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Development of P4 Systems medicine inspired new methodologies in predictive maintenance
Trial: 23636283
Drug: Sodium intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium intake > 1200 mg/day
Trial: 19689798
Drug: Reference linoleic
RxNorm normalized name: linoleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference linoleic acid oil preparation
Trial: 17239165
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg clopidogrel loading dose + 325 mg ASA
Trial: 17239165
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg clopidogrel loading dose + 325 mg ASA
Trial: 11521985
Drug: L-NAME 180
RxNorm normalized name: L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-NAME 180 microg/kg/h
Trial: 11521985
Drug: Intraduodenal lipid
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraduodenal lipid infusion (2 kcal/min)
Trial: 9972119
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg doxycycline BID (Periostat)
Trial: 3290018
Drug: sorbinil (aldose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sorbinil (aldose reductase inhibitor)
Trial: 18253118
Drug: Irinotecan 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irinotecan 60 mg m(‐2) on days 1 and 8 and cisplatin 60 mg m(‐2) on day 1 with etoposide 50 mg m(‐2) on days 1‐3 (n=55)
Trial: 18253118
Drug: Irinotecan 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irinotecan 60 mg m(‐2) on days 1 and 8 and cisplatin 60 mg m(‐2) on day 1 without etoposide (n=54)
Trial: 10477777
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg of enoxaparin
Trial: 10477777
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of enoxaparin
Trial: 1467096
Drug: i.m. morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.m. morphine 0.15 mg kg‐1 as required
Trial: 1467096
Drug: Patient-controlled analgesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-controlled analgesia (PCA) with i.v. morphine 1 mg and a 5-min lock out time
Trial: 20053951
Drug: EMG‐BFB treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EMG‐BFB treatment
Trial: 9665239
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (conventional therapy)
Trial: 18725513
Drug: 0.625 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.625 mg/day of conjugated equine estrogen plus 2.5 mg/day of medroxyprogesterone acetate